A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection

Gut

Volumn 65, Issue 10, 2016, Pages 1754-1764

  Zhang, David Y ^a   Goossens, Nicolas ^a,b   Guo, Jinsheng ^a,c   Tsai, Ming Chao ^a,d   Chou, Hsin I ^a   Altunkaynak, Civan ^a   Sangiovanni, Angelo ^e   Iavarone, Massimo ^e   Colombo, Massomo ^e   Kobayashi, Masahiro ^f   Kumada, Hiromitsu ^f   Villanueva, Augusto ^a   Llovet, Josep M ^a,g,h   Hoshida, Yujin ^a   Friedman, Scott L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c FUDAN UNIVERSITY   (China)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e UNIVERSITY OF MILAN   (Italy)

^f TORANOMON HOSPITAL   (Japan)

^g UNIVERSITY OF BARCELONA   (Spain)

^h INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BLEOMYCIN; FOCAL ADHESION KINASE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR TYPE I; MATRIX METALLOPROTEINASE; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; SCLEROPROTEIN; TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; CHILD PUGH SCORE; COHORT ANALYSIS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE COURSE; ENRICHMENT CULTURE; GENE EXPRESSION; GENE ONTOLOGY; HEPATITIS C; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LUNG FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; SURVIVAL RATE; THROMBOCYTE COUNT; UPREGULATION; ANIMAL; CARCINOMA, HEPATOCELLULAR; COMPLICATION; GENE EXPRESSION PROFILING; GENETICS; HEPATIC STELLATE CELL; LIVER NEOPLASMS; MOUSE; PATHOLOGY; PHYSIOLOGY; PROCEDURES; RAT; RECURRENT DISEASE; RISK ASSESSMENT;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; HEPATIC STELLATE CELLS; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICE; PROGNOSIS; RATS; RECURRENCE; RISK ASSESSMENT; TRANSCRIPTOME;

EID: 84990226116     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-309655     Document Type: Article

References (33)

1. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.
2. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-69.
3. Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: one function, multiple origins. Am J Pathol 2007;170:1807-16.
4. Friedman SL. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 2008;88:125-72.
5. Puche JE, Lee YA, Jiao J, et al. A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology 2013;57:339-50.
6. Tseng GC, Ghosh D, Feingold E. Comprehensive literature review and statistical considerations for microarray meta-Analysis. Nucleic Acids Res 2012;40:3785-99.
7. Kim H, Kim K, Yu SJ, et al. Development of biomarkers for screening hepatocellular carcinoma using global data mining and multiple reaction monitoring. PLoS One 2013;8;e63468.
8. Blaauboer ME, Emson CL, Verschuren L, et al. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways. Matrix Biology 2013;32:424-31.
9. Hoshida Y, Nijman SM, Kobayashi M, et al. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 2009;69:7385-92.
10. Hoshida Y, Villanueva A, Sangiovanni A, et al. Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. Gastroenterology 2013;144:1024-30.
11. Hoshida Y, Villanueva A, Kobayashi M, et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 2008;359:1995-2004.
12. Lalazar A, Wong L, Yamasaki G, et al. Early genes induced in hepatic stellate cells during wound healing. Gene 1997;195:235-43.
13. De Minicis S, Seki E, Uchinami H, et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007;132:1937-46.
14. Troeger JS, Mederacke I, Gwak GY, et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology 2012;143:1073-83 e22.
15. Kisseleva T, Brenner DA. Inactivation of myofibroblasts during regression of liver fibrosis. Cell Cycle 2013;12:381-2.
16. Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
17. Reich M, Liefeld T, Gould J, et al. GenePattern 2.0. Nature Genetics 2006;38:500-1.
18. Sprenger J, Lynn Fink J, Karunaratne S, et al. LOCATE: a mammalian protein subcellular localization database. Nucleic Acids Res 2008;36:D230-3.
19. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009; 4:44-57.
20. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Research 2009;37:1-13.
21. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. P Natl Acad Sci USA 2005;102:15545-50.
22. Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003;34:267-73.
23. Ankoma-Sey V, Matli M, Chang KB, et al. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 1998;17:115-21.
24. Yokomori H, Oda M, Ogi M, et al. Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver. Liver 2001;21:114-22.
25. Yokomori H, Oda M, Yasogawa Y, et al. Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver. Am J Pathol 2001;159: 1353-62.
26. Inatomi O, Andoh A, Yagi Y, et al. Regulation of amphiregulin and epiregulin expression in human colonic subepithelial myofibroblasts. Int J Mol Med 2006;18:497-503.
27. Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol 2009;296: G1324-31.
28. Yoshida K, Yoshitomo-Nakagawa K, Seki N, et al. Cloning, expression analysis, and chromosomal localization of BH-protocadherin (PCDH7), a novel member of the cadherin superfamily. Genomics 1998;49:458-61.
29. Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors. J Clin Invest 1989;84:1780-5.
30. Gressner AM. Cytokines and cellular crosstalk involved in the activation of fat-storing cells. J Hepatol 1995;22:28-36.
31. Kinnman N, Goria O, Wendum D, et al. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury. Lab Invest 2001;81:1709-16.
32. Wurmbach E, Chen YB, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 2007;45:938-47.
33. Mellentin JD, Murre C, Donlon TA, et al. The gene for enhancer binding proteins E12/.E47 lies at the t(1;19) breakpoint in acute leukemias. Science 1989;246:379-82.